Distribution of TLR9 and uptake of CpG in human neutrophils

被引：0

作者：

Hedrick, TL ^{[1
]}

Smith, RL ^{[1
]}

King, CS ^{[1
]}

McElearney, ST ^{[1
]}

Saalwachter, AR ^{[1
]}

Rudy, CK ^{[1
]}

Du, KP ^{[1
]}

Pruett, TL ^{[1
]}

Sawyer, RG ^{[1
]}

机构：

[1] Univ Virginia Hlth Syst, Charlottesville, VA 22908 USA

来源：

FASEB JOURNAL | 2005年 / 19卷 / 04期

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：A373 / A373

页数：1

共 50 条

[21] The Functional Role of TLR9 in Human Platelets
Thon, Jonathan Noah
Peters, Christian G.
Aslam, Rukhsana
Rowley, Jesse
Weyrich, Andrew S.
Semple, John W.
Flaumenhaft, Robert C.
Italian, Joseph E., Jr.
BLOOD, 2011, 118 (21) : 171 - 171
[22] Expression of TLR9 within human glioblastoma
Meng, Yuxia
Kujas, Michele
Marie, Yannick
Paris, Sophie
Thillet, Joelle
Delattre, Jean-Yves
Carpentier, Antoine F.
JOURNAL OF NEURO-ONCOLOGY, 2008, 88 (01) : 19 - 25
[23] Therapeutic applications of synthetic CpG oligodeoxynucleotides as TLR9 agonists for immune modulation
Jurk, Marion
Vollmer, Jorg
BIODRUGS, 2007, 21 (06) : 387 - 401
[24] TLR9免疫识别CpG DNA的机制与途径
李宁
国外医学(分子生物学分册), 2003, (05) : 291 - 294
[25] Development of CpG oligodeoxynucleotide TLR9 agonists in anti-cancer therapy
Jin, Yizhen
Zhuang, Yuxin
Dong, Xiaowu
Liu, Mei
EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (08) : 841 - 851
[26] Differential signaling by CpG DNA in DCs and B cells: not just TLR9
Verthelyi, D
Zeuner, RA
TRENDS IN IMMUNOLOGY, 2003, 24 (10) : 519 - 522
[27] In Vivo TLR9 Inhibition Attenuates CpG-Induced Myocardial Dysfunction
Boehm, O.
Markowski, P.
van der Giet, M.
Gielen, V.
Kokalova, A.
Brill, C.
Hoeft, A.
Baumgarten, G.
Meyer, R.
Knuefermann, P.
MEDIATORS OF INFLAMMATION, 2013, 2013
[28] Therapeutic Applications of Synthetic CpG Oligodeoxynucleotides as TLR9 Agonists for Immune Modulation
Marion Jurk
Jörg Vollmer
BioDrugs, 2007, 21 : 387 - 401
[29] TLR9 KO MICE, HAPLOTYPES AND CPG INDICES IN CHLAMYDIA TRACHOMATIS INFECTION
Ouburg, S.
Lyons, J. M.
Land, J. A.
den Hartog, J. E.
Fennema, J. S. A.
de Vries, H. J. C.
Bruggeman, C. A.
Ito, J. I.
Pena, A. S.
Lundberg, P. S. J.
Morre, S. A.
DRUGS OF TODAY, 2009, 45 : 83 - 93
[30] TLR9 signals after translocating from the ER to CpG DNA in the lysosome
Latz, E
Schoenemeyer, A
Visintin, A
Fitzgerald, KA
Monks, BG
Knetter, CF
Lien, E
Nilsen, NJ
Espevik, T
Golenbock, DT
NATURE IMMUNOLOGY, 2004, 5 (02) : 190 - 198

← 1 2 3 4 5 →